Image (F31ceaaa 0c41 499d Beb2 F5e2d90cd7ec 01)
Mycophenolate Mofetil Capsule
Product Images NDC 68254-5000
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 68254-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Concord Biotech Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (F31ceaaa 0c41 499d Beb2 F5e2d90cd7ec 02)
Mycophenolate Mofetil Capsules, USP contain 250mg per capsule. Dosage recommendations and further prescribing instructions are provided within the accompanying insert. The capsules should be stored in a suitable container with a child-resistant cap, in a controlled room temperature between 15°C to 30°C (59°F to 86°F). The medication guide should be dispensed to each patient, and special handling and disposal instructions should be followed, as indicated in the insert. Manufactured by Concord Biotech Limited, these capsules can only be dispensed with a prescription.*
Image (F31ceaaa 0c41 499d Beb2 F5e2d90cd7ec 03)
Each Mycophenolate Mofetil, USP 250 mg capsule is manufactured by Concord Biotech Limited and should be dispensed in a tight, light-resistant container as defined in USP with a child-resistant cap. The medication guide should be dispensed to each patient. It is recommended to store the capsules at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). For further information, please refer to the insert for dosage recommendations, special handling, and disposal instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
